Global Minimal Residual Disease Testing Market Size, Share & Industry Trends Analysis Report By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors and Others), By End User, By Technology, By Regional Outlook and Forecast, 2022 - 2028

The Global Minimal Residual Disease Testing Market size is expected to reach $2.7 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period.

Minimal residual disease (MRD) testing is performed to identify solid tumors or hematological malignancies. MRD tests are mostly utilized for the diagnosis of a residual diagnosis in research and clinical settings. Through this test, the oncologists receive individualized information on the effectiveness of the utilized therapy from the ongoing monitoring of leftover cancer cells during the core therapy and throughout the remission stage.

Consequently, MRD tests also affect the decision-making for the selection of efficient treatment that would result in the improvement of the therapeutic results. Additionally, these tests can accurately forecast the likelihood of potential disease relapse. The onset of hematological malignancies or blood cancers takes place in the bone marrow, where stem cells give rise to red blood cells (RBC), white blood cells (WBC), and platelets.

These diseases affect the proper generation and operation of blood cells. These malignancies form when the development of healthy blood cells is obstructed by the unchecked proliferation of abnormal cells, which interferes with the normal functions of healthy cells. MRD is also known as measurable residual testing, and its test methods are used to determine the efficacy of cancer treatment and the need to direct future treatment strategies.

Leukemia, lymphoma, and myeloma are the three blood malignancies for which MRD testing is most commonly utilized, while its usage for other diseases’ diagnoses is being researched. In addition, since the outcomes can be utilized to customize a patient’s therapy, these tests are often considered helpful in the development of customized medicine.

COVID-19 Impact Analysis

The modifications to treatment occurred at a considerably slow pace owing to the pandemic’s urgency. As a result, the setup of optimal time points to assess the disease response and evaluate for relapse by measuring the minimal residual disease for the newer methods could not be adequately established. This further made the intensification of therapy challenging by not providing an apt description of the therapy’s duration and time points. Therefore, the COVID-19 pandemic had a negative effect on the minimal residual disease testing market.

Market Growth Factors

Increasing Cases Of Hematological Malignancies Across The World

Since the past few decades, the incidences of hematological malignancies have risen significantly. This increase includes the rising prevalence of hematological cancer subtypes as well. For example, leukemia was the eleventh leading mortality-causing factor that was associated with cancer in 2018. According to the Surveillance, Epidemiology, and End Results (SEER) Program, the disease also accounted for around 3.2% of all new emerging cancer cases in 2022.

Growing Use Of MRD Test Methods In The Diagnosis And Care Of Various Cancers

Since their development, minimal residual disease testing methods have become an essential part of the diagnosis of various blood cancers type. In acute lymphocytic leukemia (ALL), MRD tests are an integral part of routine testing. Several studies have also suggested that MRD tests are the most appropriate way to determine the appropriate treatment that would be extremely helpful for the first ALL therapy. These tests also help in the identification of patients that are at risk of relapse. Such factors aid in the expansion of the minimal residual disease testing market significantly.

Market Restraining Factors

Complex And Strict Regulations Regarding The Application Of MRD Tests

Like any other treatment and diagnostic methods, the minimal residual disease testing methodologies are also subject to specific issues related to the usage and suitability of these tests. The issue varies according to the tests. For example, multiparameter flow cytometry tests include complex data visualization, and these tests are unable to detect cytogenetic characteristics. Therefore, the strict regulations, along with the drawbacks of MRD tests, hampers the expansion and growth of the minimal residual disease testing market.

Technology Outlook

Based on technology, the minimal residual disease testing market is categorized into flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and other technologies. The polymerase chain reaction (PCR) segment garnered the highest revenue share in the minimal residual disease testing market in 2021. The growth of the segment is because of the high practicality and simplicity of the PCR diagnostic devices in minimal residual disease testing. In addition, the PCR diagnostic device kits offer increased accessibility to information with a higher degree of sensitivity.

Application Outlook

On the basis of application, the minimal residual disease testing market is divided into hematological malignancies, leukemia, lymphoma, solid tumors, and other applications. The hematological malignancies segment acquired the largest revenue share in the minimal residual disease testing market in 2021. Cancers that start forming in blood-forming tissue like bone marrow are called hematological malignancies. Lymphoma, multiple myeloma, and leukemia are all types of hematological malignancies. MRD testing using PCR diagnosis enable the identification of cancer cells, including the rare kinds which are detectable in peripheral blood or bone marrow.

End User Outlook

Based on end user, the minimal residual disease testing market is segmented into hospitals & specialty clinics, diagnostic laboratories, academic & research institutions, and others. The academic and research institutions segment garnered a remarkable growth rate in the minimal residual disease testing market in 2021. In academic and research institutions, the MRD test enables the conduction of more studies on rare cancer subjects. In addition, the results of MRD tests can be included as an endpoint in reports focusing on outcomes of clinical trials, which increases their use in clinical practices as well.

Minimal Residual Disease Testing Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 1.1 Billion
Market size forecast in 2028	USD 2.7 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 14.2% from 2022 to 2028
Number of Pages	246
Number of Tables	390
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Technology, Application, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Increasing Cases Of Hematological Malignancies Across The World Growing Use Of MRD Test Methods In The Diagnosis And Care Of Various Cancers
Restraints	Complex And Strict Regulations Regarding The Application Of MRD Tests

Regional Outlook

On the basis of region, the minimal residual disease testing market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the minimal residual disease testing market in 2021. MRD testing in North America is developing as a result of quick technological advancements, rising R&D expenditures, a developing patent pool along with an increase in applications.

Free Valuable Insights: Global Minimal Residual Disease Testing Market size to reach USD 2.7 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Rad Laboratories, Inc., Guardant Health, Inc., Invitae Corporation (ArcherDX, Inc.), Bio-Techne Corporation, F. Hoffmann-La Roche Ltd., ICON plc (MolecularMD Corporation), Natera, Inc., Sysmex Corporation, Laboratory Corporation of America Holdings, and Invivoscribe, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Hematological Malignancies
• Leukemia
• Lymphoma
• Solid Tumors
• Others

By End User

• Hospitals & Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Others

By Technology

• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Flow Cytometry
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Bio-Rad Laboratories, Inc.
• Guardant Health, Inc.
• Invitae Corporation (ArcherDX, Inc.)
• Bio-Techne Corporation
• F.Hoffmann-La Roche Ltd.
• ICON plc (MolecularMD Corporation)
• Natera, Inc.
• Sysmex Corporation
• Laboratory Corporation of America Holdings
• Invivoscribe, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Minimal Residual Disease Testing Market, by Application
1.4.2 Global Minimal Residual Disease Testing Market, by End User
1.4.3 Global Minimal Residual Disease Testing Market, by Technology
1.4.4 Global Minimal Residual Disease Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Minimal Residual Disease Testing Market by Application
3.1 Global Hematological Malignancies Market by Region
3.2 Global Leukemia Market by Region
3.3 Global Lymphoma Market by Region
3.4 Global Solid Tumors Market by Region
3.5 Global Others Market by Region

Chapter 4. Global Minimal Residual Disease Testing Market by End User
4.1 Global Hospitals & Specialty Clinics Market by Region
4.2 Global Diagnostic Laboratories Market by Region
4.3 Global Academic & Research Institutes Market by Region
4.4 Global Others Market by Region

Chapter 5. Global Minimal Residual Disease Testing Market by Technology
5.1 Global Polymerase Chain Reaction (PCR) Market by Region
5.2 Global Next-Generation Sequencing (NGS) Market by Region
5.3 Global Flow Cytometry Market by Region
5.4 Global Others Market by Region

Chapter 6. Global Minimal Residual Disease Testing Market by Region
6.1 North America Minimal Residual Disease Testing Market
6.1.1 North America Minimal Residual Disease Testing Market by Application
6.1.1.1 North America Hematological Malignancies Market by Country
6.1.1.2 North America Leukemia Market by Country
6.1.1.3 North America Lymphoma Market by Country
6.1.1.4 North America Solid Tumors Market by Country
6.1.1.5 North America Others Market by Country
6.1.2 North America Minimal Residual Disease Testing Market by End User
6.1.2.1 North America Hospitals & Specialty Clinics Market by Country
6.1.2.2 North America Diagnostic Laboratories Market by Country
6.1.2.3 North America Academic & Research Institutes Market by Country
6.1.2.4 North America Others Market by Country
6.1.3 North America Minimal Residual Disease Testing Market by Technology
6.1.3.1 North America Polymerase Chain Reaction (PCR) Market by Country
6.1.3.2 North America Next-Generation Sequencing (NGS) Market by Country
6.1.3.3 North America Flow Cytometry Market by Country
6.1.3.4 North America Others Market by Country
6.1.4 North America Minimal Residual Disease Testing Market by Country
6.1.4.1 US Minimal Residual Disease Testing Market
6.1.4.1.1 US Minimal Residual Disease Testing Market by Application
6.1.4.1.2 US Minimal Residual Disease Testing Market by End User
6.1.4.1.3 US Minimal Residual Disease Testing Market by Technology
6.1.4.2 Canada Minimal Residual Disease Testing Market
6.1.4.2.1 Canada Minimal Residual Disease Testing Market by Application
6.1.4.2.2 Canada Minimal Residual Disease Testing Market by End User
6.1.4.2.3 Canada Minimal Residual Disease Testing Market by Technology
6.1.4.3 Mexico Minimal Residual Disease Testing Market
6.1.4.3.1 Mexico Minimal Residual Disease Testing Market by Application
6.1.4.3.2 Mexico Minimal Residual Disease Testing Market by End User
6.1.4.3.3 Mexico Minimal Residual Disease Testing Market by Technology
6.1.4.4 Rest of North America Minimal Residual Disease Testing Market
6.1.4.4.1 Rest of North America Minimal Residual Disease Testing Market by Application
6.1.4.4.2 Rest of North America Minimal Residual Disease Testing Market by End User
6.1.4.4.3 Rest of North America Minimal Residual Disease Testing Market by Technology
6.2 Europe Minimal Residual Disease Testing Market
6.2.1 Europe Minimal Residual Disease Testing Market by Application
6.2.1.1 Europe Hematological Malignancies Market by Country
6.2.1.2 Europe Leukemia Market by Country
6.2.1.3 Europe Lymphoma Market by Country
6.2.1.4 Europe Solid Tumors Market by Country
6.2.1.5 Europe Others Market by Country
6.2.2 Europe Minimal Residual Disease Testing Market by End User
6.2.2.1 Europe Hospitals & Specialty Clinics Market by Country
6.2.2.2 Europe Diagnostic Laboratories Market by Country
6.2.2.3 Europe Academic & Research Institutes Market by Country
6.2.2.4 Europe Others Market by Country
6.2.3 Europe Minimal Residual Disease Testing Market by Technology
6.2.3.1 Europe Polymerase Chain Reaction (PCR) Market by Country
6.2.3.2 Europe Next-Generation Sequencing (NGS) Market by Country
6.2.3.3 Europe Flow Cytometry Market by Country
6.2.3.4 Europe Others Market by Country
6.2.4 Europe Minimal Residual Disease Testing Market by Country
6.2.4.1 Germany Minimal Residual Disease Testing Market
6.2.4.1.1 Germany Minimal Residual Disease Testing Market by Application
6.2.4.1.2 Germany Minimal Residual Disease Testing Market by End User
6.2.4.1.3 Germany Minimal Residual Disease Testing Market by Technology
6.2.4.2 UK Minimal Residual Disease Testing Market
6.2.4.2.1 UK Minimal Residual Disease Testing Market by Application
6.2.4.2.2 UK Minimal Residual Disease Testing Market by End User
6.2.4.2.3 UK Minimal Residual Disease Testing Market by Technology
6.2.4.3 France Minimal Residual Disease Testing Market
6.2.4.3.1 France Minimal Residual Disease Testing Market by Application
6.2.4.3.2 France Minimal Residual Disease Testing Market by End User
6.2.4.3.3 France Minimal Residual Disease Testing Market by Technology
6.2.4.4 Russia Minimal Residual Disease Testing Market
6.2.4.4.1 Russia Minimal Residual Disease Testing Market by Application
6.2.4.4.2 Russia Minimal Residual Disease Testing Market by End User
6.2.4.4.3 Russia Minimal Residual Disease Testing Market by Technology
6.2.4.5 Spain Minimal Residual Disease Testing Market
6.2.4.5.1 Spain Minimal Residual Disease Testing Market by Application
6.2.4.5.2 Spain Minimal Residual Disease Testing Market by End User
6.2.4.5.3 Spain Minimal Residual Disease Testing Market by Technology
6.2.4.6 Italy Minimal Residual Disease Testing Market
6.2.4.6.1 Italy Minimal Residual Disease Testing Market by Application
6.2.4.6.2 Italy Minimal Residual Disease Testing Market by End User
6.2.4.6.3 Italy Minimal Residual Disease Testing Market by Technology
6.2.4.7 Rest of Europe Minimal Residual Disease Testing Market
6.2.4.7.1 Rest of Europe Minimal Residual Disease Testing Market by Application
6.2.4.7.2 Rest of Europe Minimal Residual Disease Testing Market by End User
6.2.4.7.3 Rest of Europe Minimal Residual Disease Testing Market by Technology
6.3 Asia Pacific Minimal Residual Disease Testing Market
6.3.1 Asia Pacific Minimal Residual Disease Testing Market by Application
6.3.1.1 Asia Pacific Hematological Malignancies Market by Country
6.3.1.2 Asia Pacific Leukemia Market by Country
6.3.1.3 Asia Pacific Lymphoma Market by Country
6.3.1.4 Asia Pacific Solid Tumors Market by Country
6.3.1.5 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Minimal Residual Disease Testing Market by End User
6.3.2.1 Asia Pacific Hospitals & Specialty Clinics Market by Country
6.3.2.2 Asia Pacific Diagnostic Laboratories Market by Country
6.3.2.3 Asia Pacific Academic & Research Institutes Market by Country
6.3.2.4 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Minimal Residual Disease Testing Market by Technology
6.3.3.1 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country
6.3.3.2 Asia Pacific Next-Generation Sequencing (NGS) Market by Country
6.3.3.3 Asia Pacific Flow Cytometry Market by Country
6.3.3.4 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Minimal Residual Disease Testing Market by Country
6.3.4.1 China Minimal Residual Disease Testing Market
6.3.4.1.1 China Minimal Residual Disease Testing Market by Application
6.3.4.1.2 China Minimal Residual Disease Testing Market by End User
6.3.4.1.3 China Minimal Residual Disease Testing Market by Technology
6.3.4.2 Japan Minimal Residual Disease Testing Market
6.3.4.2.1 Japan Minimal Residual Disease Testing Market by Application
6.3.4.2.2 Japan Minimal Residual Disease Testing Market by End User
6.3.4.2.3 Japan Minimal Residual Disease Testing Market by Technology
6.3.4.3 India Minimal Residual Disease Testing Market
6.3.4.3.1 India Minimal Residual Disease Testing Market by Application
6.3.4.3.2 India Minimal Residual Disease Testing Market by End User
6.3.4.3.3 India Minimal Residual Disease Testing Market by Technology
6.3.4.4 South Korea Minimal Residual Disease Testing Market
6.3.4.4.1 South Korea Minimal Residual Disease Testing Market by Application
6.3.4.4.2 South Korea Minimal Residual Disease Testing Market by End User
6.3.4.4.3 South Korea Minimal Residual Disease Testing Market by Technology
6.3.4.5 Singapore Minimal Residual Disease Testing Market
6.3.4.5.1 Singapore Minimal Residual Disease Testing Market by Application
6.3.4.5.2 Singapore Minimal Residual Disease Testing Market by End User
6.3.4.5.3 Singapore Minimal Residual Disease Testing Market by Technology
6.3.4.6 Malaysia Minimal Residual Disease Testing Market
6.3.4.6.1 Malaysia Minimal Residual Disease Testing Market by Application
6.3.4.6.2 Malaysia Minimal Residual Disease Testing Market by End User
6.3.4.6.3 Malaysia Minimal Residual Disease Testing Market by Technology
6.3.4.7 Rest of Asia Pacific Minimal Residual Disease Testing Market
6.3.4.7.1 Rest of Asia Pacific Minimal Residual Disease Testing Market by Application
6.3.4.7.2 Rest of Asia Pacific Minimal Residual Disease Testing Market by End User
6.3.4.7.3 Rest of Asia Pacific Minimal Residual Disease Testing Market by Technology
6.4 LAMEA Minimal Residual Disease Testing Market
6.4.1 LAMEA Minimal Residual Disease Testing Market by Application
6.4.1.1 LAMEA Hematological Malignancies Market by Country
6.4.1.2 LAMEA Leukemia Market by Country
6.4.1.3 LAMEA Lymphoma Market by Country
6.4.1.4 LAMEA Solid Tumors Market by Country
6.4.1.5 LAMEA Others Market by Country
6.4.2 LAMEA Minimal Residual Disease Testing Market by End User
6.4.2.1 LAMEA Hospitals & Specialty Clinics Market by Country
6.4.2.2 LAMEA Diagnostic Laboratories Market by Country
6.4.2.3 LAMEA Academic & Research Institutes Market by Country
6.4.2.4 LAMEA Others Market by Country
6.4.3 LAMEA Minimal Residual Disease Testing Market by Technology
6.4.3.1 LAMEA Polymerase Chain Reaction (PCR) Market by Country
6.4.3.2 LAMEA Next-Generation Sequencing (NGS) Market by Country
6.4.3.3 LAMEA Flow Cytometry Market by Country
6.4.3.4 LAMEA Others Market by Country
6.4.4 LAMEA Minimal Residual Disease Testing Market by Country
6.4.4.1 Brazil Minimal Residual Disease Testing Market
6.4.4.1.1 Brazil Minimal Residual Disease Testing Market by Application
6.4.4.1.2 Brazil Minimal Residual Disease Testing Market by End User
6.4.4.1.3 Brazil Minimal Residual Disease Testing Market by Technology
6.4.4.2 Argentina Minimal Residual Disease Testing Market
6.4.4.2.1 Argentina Minimal Residual Disease Testing Market by Application
6.4.4.2.2 Argentina Minimal Residual Disease Testing Market by End User
6.4.4.2.3 Argentina Minimal Residual Disease Testing Market by Technology
6.4.4.3 UAE Minimal Residual Disease Testing Market
6.4.4.3.1 UAE Minimal Residual Disease Testing Market by Application
6.4.4.3.2 UAE Minimal Residual Disease Testing Market by End User
6.4.4.3.3 UAE Minimal Residual Disease Testing Market by Technology
6.4.4.4 Saudi Arabia Minimal Residual Disease Testing Market
6.4.4.4.1 Saudi Arabia Minimal Residual Disease Testing Market by Application
6.4.4.4.2 Saudi Arabia Minimal Residual Disease Testing Market by End User
6.4.4.4.3 Saudi Arabia Minimal Residual Disease Testing Market by Technology
6.4.4.5 South Africa Minimal Residual Disease Testing Market
6.4.4.5.1 South Africa Minimal Residual Disease Testing Market by Application
6.4.4.5.2 South Africa Minimal Residual Disease Testing Market by End User
6.4.4.5.3 South Africa Minimal Residual Disease Testing Market by Technology
6.4.4.6 Nigeria Minimal Residual Disease Testing Market
6.4.4.6.1 Nigeria Minimal Residual Disease Testing Market by Application
6.4.4.6.2 Nigeria Minimal Residual Disease Testing Market by End User
6.4.4.6.3 Nigeria Minimal Residual Disease Testing Market by Technology
6.4.4.7 Rest of LAMEA Minimal Residual Disease Testing Market
6.4.4.7.1 Rest of LAMEA Minimal Residual Disease Testing Market by Application
6.4.4.7.2 Rest of LAMEA Minimal Residual Disease Testing Market by End User
6.4.4.7.3 Rest of LAMEA Minimal Residual Disease Testing Market by Technology

Chapter 7. Company Profiles
7.1 Bio-Rad Laboratories, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.2 Guardant Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.3 Invitae Corporation (ArcherDX, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Bio-Techne Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trails:
7.6 ICON plc (MolecularMD Corporation)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Natera Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Sysmex Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Laboratory Corporation of America Holdings
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Partnerships, Collaborations, and Agreements:
7.9.4.2 Product Launches and Product Expansions:
7.10. Invivoscribe, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:

TABLE 1 Global Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 2 Global Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 3 Global Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 4 Global Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 5 Global Hematological Malignancies Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Hematological Malignancies Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Leukemia Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Leukemia Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Lymphoma Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Lymphoma Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Solid Tumors Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Solid Tumors Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 16 Global Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 17 Global Hospitals & Specialty Clinics Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Hospitals & Specialty Clinics Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Diagnostic Laboratories Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Diagnostic Laboratories Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Academic & Research Institutes Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Academic & Research Institutes Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 26 Global Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 27 Global Polymerase Chain Reaction (PCR) Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Polymerase Chain Reaction (PCR) Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Next-Generation Sequencing (NGS) Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Next-Generation Sequencing (NGS) Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Flow Cytometry Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Flow Cytometry Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Minimal Residual Disease Testing Market by Region, 2018 - 2021, USD Million
TABLE 36 Global Minimal Residual Disease Testing Market by Region, 2022 - 2028, USD Million
TABLE 37 North America Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 38 North America Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 39 North America Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 40 North America Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 41 North America Hematological Malignancies Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Hematological Malignancies Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Solid Tumors Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Solid Tumors Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 52 North America Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 53 North America Hospitals & Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Hospitals & Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 62 North America Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 63 North America Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Next-Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Next-Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Minimal Residual Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 72 North America Minimal Residual Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 73 US Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 74 US Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 75 US Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 76 US Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 77 US Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 78 US Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 79 US Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 80 US Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 81 Canada Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 82 Canada Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 83 Canada Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 84 Canada Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 85 Canada Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 86 Canada Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 87 Canada Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 88 Canada Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 89 Mexico Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 90 Mexico Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 91 Mexico Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 92 Mexico Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 93 Mexico Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 94 Mexico Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 95 Mexico Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 96 Mexico Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 97 Rest of North America Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 98 Rest of North America Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 99 Rest of North America Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 100 Rest of North America Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 101 Rest of North America Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 102 Rest of North America Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 103 Rest of North America Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 104 Rest of North America Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 105 Europe Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 106 Europe Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 107 Europe Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 108 Europe Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 109 Europe Hematological Malignancies Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Hematological Malignancies Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Solid Tumors Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Solid Tumors Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 120 Europe Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 121 Europe Hospitals & Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Hospitals & Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 123 Europe Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 124 Europe Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 125 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 126 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 127 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 128 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 129 Europe Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 130 Europe Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 131 Europe Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
TABLE 132 Europe Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
TABLE 133 Europe Next-Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
TABLE 134 Europe Next-Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
TABLE 135 Europe Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 136 Europe Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 137 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Minimal Residual Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 140 Europe Minimal Residual Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 141 Germany Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 142 Germany Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 143 Germany Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 144 Germany Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 145 Germany Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 146 Germany Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 147 Germany Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 148 Germany Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 149 UK Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 150 UK Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 151 UK Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 152 UK Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 153 UK Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 154 UK Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 155 UK Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 156 UK Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 157 France Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 158 France Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 159 France Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 160 France Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 161 France Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 162 France Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 163 France Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 164 France Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 165 Russia Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 166 Russia Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 167 Russia Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 168 Russia Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 169 Russia Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 170 Russia Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 171 Russia Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 172 Russia Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 173 Spain Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 174 Spain Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 175 Spain Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 176 Spain Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 177 Spain Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 178 Spain Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 179 Spain Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 180 Spain Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 181 Italy Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 182 Italy Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 183 Italy Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 184 Italy Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 185 Italy Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 186 Italy Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 187 Italy Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 188 Italy Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 189 Rest of Europe Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 190 Rest of Europe Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 191 Rest of Europe Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 192 Rest of Europe Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 193 Rest of Europe Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 194 Rest of Europe Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 195 Rest of Europe Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 196 Rest of Europe Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Hematological Malignancies Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Hematological Malignancies Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Solid Tumors Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Solid Tumors Market by Country, 2022 - 2028, USD Million
TABLE 209 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 210 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 211 Asia Pacific Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 212 Asia Pacific Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 213 Asia Pacific Hospitals & Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 214 Asia Pacific Hospitals & Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 215 Asia Pacific Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 216 Asia Pacific Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 217 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 218 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 219 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 220 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 221 Asia Pacific Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 222 Asia Pacific Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 223 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
TABLE 224 Asia Pacific Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
TABLE 225 Asia Pacific Next-Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
TABLE 226 Asia Pacific Next-Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
TABLE 227 Asia Pacific Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 228 Asia Pacific Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 229 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 230 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 231 Asia Pacific Minimal Residual Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 232 Asia Pacific Minimal Residual Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 233 China Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 234 China Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 235 China Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 236 China Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 237 China Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 238 China Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 239 China Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 240 China Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 241 Japan Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 242 Japan Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 243 Japan Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 244 Japan Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 245 Japan Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 246 Japan Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 247 Japan Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 248 Japan Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 249 India Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 250 India Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 251 India Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 252 India Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 253 India Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 254 India Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 255 India Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 256 India Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 257 South Korea Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 258 South Korea Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 259 South Korea Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 260 South Korea Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 261 South Korea Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 262 South Korea Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 263 South Korea Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 264 South Korea Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 265 Singapore Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 266 Singapore Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 267 Singapore Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 268 Singapore Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 269 Singapore Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 270 Singapore Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 271 Singapore Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 272 Singapore Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 273 Malaysia Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 274 Malaysia Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 275 Malaysia Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 276 Malaysia Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 277 Malaysia Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 278 Malaysia Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 279 Malaysia Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 280 Malaysia Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 281 Rest of Asia Pacific Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 282 Rest of Asia Pacific Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 283 Rest of Asia Pacific Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 284 Rest of Asia Pacific Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 285 Rest of Asia Pacific Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 286 Rest of Asia Pacific Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 287 Rest of Asia Pacific Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 288 Rest of Asia Pacific Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 289 LAMEA Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 290 LAMEA Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 291 LAMEA Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 292 LAMEA Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 293 LAMEA Hematological Malignancies Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Hematological Malignancies Market by Country, 2022 - 2028, USD Million
TABLE 295 LAMEA Leukemia Market by Country, 2018 - 2021, USD Million
TABLE 296 LAMEA Leukemia Market by Country, 2022 - 2028, USD Million
TABLE 297 LAMEA Lymphoma Market by Country, 2018 - 2021, USD Million
TABLE 298 LAMEA Lymphoma Market by Country, 2022 - 2028, USD Million
TABLE 299 LAMEA Solid Tumors Market by Country, 2018 - 2021, USD Million
TABLE 300 LAMEA Solid Tumors Market by Country, 2022 - 2028, USD Million
TABLE 301 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 302 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 303 LAMEA Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 304 LAMEA Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 305 LAMEA Hospitals & Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 306 LAMEA Hospitals & Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 307 LAMEA Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 308 LAMEA Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 309 LAMEA Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 310 LAMEA Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 311 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 312 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 313 LAMEA Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 314 LAMEA Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 315 LAMEA Polymerase Chain Reaction (PCR) Market by Country, 2018 - 2021, USD Million
TABLE 316 LAMEA Polymerase Chain Reaction (PCR) Market by Country, 2022 - 2028, USD Million
TABLE 317 LAMEA Next-Generation Sequencing (NGS) Market by Country, 2018 - 2021, USD Million
TABLE 318 LAMEA Next-Generation Sequencing (NGS) Market by Country, 2022 - 2028, USD Million
TABLE 319 LAMEA Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 320 LAMEA Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 321 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 322 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 323 LAMEA Minimal Residual Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 324 LAMEA Minimal Residual Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 325 Brazil Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 326 Brazil Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 327 Brazil Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 328 Brazil Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 329 Brazil Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 330 Brazil Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 331 Brazil Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 332 Brazil Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 333 Argentina Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 334 Argentina Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 335 Argentina Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 336 Argentina Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 337 Argentina Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 338 Argentina Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 339 Argentina Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 340 Argentina Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 341 UAE Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 342 UAE Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 343 UAE Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 344 UAE Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 345 UAE Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 346 UAE Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 347 UAE Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 348 UAE Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 349 Saudi Arabia Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 350 Saudi Arabia Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 351 Saudi Arabia Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 352 Saudi Arabia Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 353 Saudi Arabia Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 354 Saudi Arabia Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 355 Saudi Arabia Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 356 Saudi Arabia Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 357 South Africa Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 358 South Africa Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 359 South Africa Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 360 South Africa Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 361 South Africa Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 362 South Africa Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 363 South Africa Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 364 South Africa Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 365 Nigeria Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 366 Nigeria Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 367 Nigeria Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 368 Nigeria Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 369 Nigeria Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 370 Nigeria Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 371 Nigeria Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 372 Nigeria Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 373 Rest of LAMEA Minimal Residual Disease Testing Market, 2018 - 2021, USD Million
TABLE 374 Rest of LAMEA Minimal Residual Disease Testing Market, 2022 - 2028, USD Million
TABLE 375 Rest of LAMEA Minimal Residual Disease Testing Market by Application, 2018 - 2021, USD Million
TABLE 376 Rest of LAMEA Minimal Residual Disease Testing Market by Application, 2022 - 2028, USD Million
TABLE 377 Rest of LAMEA Minimal Residual Disease Testing Market by End User, 2018 - 2021, USD Million
TABLE 378 Rest of LAMEA Minimal Residual Disease Testing Market by End User, 2022 - 2028, USD Million
TABLE 379 Rest of LAMEA Minimal Residual Disease Testing Market by Technology, 2018 - 2021, USD Million
TABLE 380 Rest of LAMEA Minimal Residual Disease Testing Market by Technology, 2022 - 2028, USD Million
TABLE 381 Key Information – Bio-Rad Laboratories, Inc.
TABLE 382 Key Information – Guardant Health, Inc.
TABLE 383 Key Information – Invitae Corporation
TABLE 384 Key Information – Bio-Techne Corporation
TABLE 385 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 386 Key Information – ICON PLC
TABLE 387 Key Information – Natera Inc.
TABLE 388 key information – Sysmex Corporation
TABLE 389 Key Information – Laboratory Corporation of America holdings
TABLE 390 Key Information – Invivoscribe, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Minimal Residual Disease Testing Market Share by Application, 2021
FIG 3 Global Minimal Residual Disease Testing Market Share by Application, 2028
FIG 4 Global Minimal Residual Disease Testing Market by Application, 2018 - 2028, USD Million
FIG 5 Global Minimal Residual Disease Testing Market Share by End User, 2021
FIG 6 Global Minimal Residual Disease Testing Market Share by End User, 2028
FIG 7 Global Minimal Residual Disease Testing Market by End User, 2018 - 2028, USD Million
FIG 8 Global Minimal Residual Disease Testing Market Share by Technology, 2021
FIG 9 Global Minimal Residual Disease Testing Market Share by Technology, 2028
FIG 10 Global Minimal Residual Disease Testing Market by Technology, 2018 - 2028, USD Million
FIG 11 Global Minimal Residual Disease Testing Market Share by Region, 2021
FIG 12 Global Minimal Residual Disease Testing Market Share by Region, 2028
FIG 13 Global Minimal Residual Disease Testing Market by Region, 2018 - 2028, USD Million
FIG 14 Recent strategies and developments: Guardant Health, Inc.
FIG 15 Recent strategies and developments: Laboratory corporation of America Holding